Nuvectis Pharma (NVCT) Stock Highlights

7.6 | +12.43%

2024-10-21 04:52:34

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. Its pipeline products include NXP800, NXP900.

Statistics

Range Today

6.8 7.76

Volume Today 383.1K

Range 1 Year

5.85 12.1

Volume 1 Year 21.73M

Range 3 Year

3.08 20.92

Volume 3 Year 129.1M

Range 10 Year

3.08 20.92

Volume 10 Year 129.1M

Highlights

Market Capitalization 141.76M (small)

Floating Shares 6.64M

Current Price 7.6

Price To Earnings -5.41

Price To Book 11.38

Earnings Per Share -1.29

Payout Ratio 0%

Performance

Latest +12.43%

1 Month +11.93%

3 Months +11.93%

6 Months +11.27%

1 Year -18.1%

3 Years +92.41%

5 Years +92.41%

10 Years +92.41%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.